We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Umbilical Cord Serum Eye Drops

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01016158
Recruitment Status : Completed
First Posted : November 19, 2009
Last Update Posted : November 19, 2009
Sponsor:
Information provided by:
Chonnam National University Hospital

Brief Summary:
In the present study, the investigators investigated the efficacy of umbilical cord serum eye drops for the treatment of patients with recurrent corneal erosions. Group A were treated with 20% umbilical cord serum eye drops 3 to 4 times a day in addition to artificial tears, and group B were treated with artificial tears only. Ophthalmic examinations including visual acuity measurement and slit lamp biomicroscopy were performed before and every month after treatment. Recurrence was defined as the presence of clinical symptoms accompanied by epithelial defects in the cornea.

Condition or disease Intervention/treatment
Recurrent Corneal Erosion Drug: Umbilical cord serum eyedrops

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Study Start Date : April 2006
Primary Completion Date : April 2009
Study Completion Date : October 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Eye Care
U.S. FDA Resources

Arm Intervention/treatment
Experimental: umbilical cord serum eyedrops
patients with recurrent corneal erosions were treated with 20% umbilical cord serum eye drops 3 to 4 times a day in addition to artificial tears
Drug: Umbilical cord serum eyedrops
20% umbilical cord serum eye drops 3 to 4 times a day




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients with recurrent corneal erosions

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01016158


Locations
Korea, Republic of
Chonnam National University Hospital
Gwang-Ju, Korea, Republic of
Sponsors and Collaborators
Chonnam National University Hospital

Publications:
Responsible Party: Kyung-Chul Yoon
ClinicalTrials.gov Identifier: NCT01016158     History of Changes
Other Study ID Numbers: I-2009-11-135
First Posted: November 19, 2009    Key Record Dates
Last Update Posted: November 19, 2009
Last Verified: November 2009

Keywords provided by Chonnam National University Hospital:
Umbilical cord serum
Recurrent corneal erosion

Additional relevant MeSH terms:
Ophthalmic Solutions
Tetrahydrozoline
Pharmaceutical Solutions
Sympathomimetics
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Nasal Decongestants
Vasoconstrictor Agents
Respiratory System Agents